1. Volume 72, Issue 5, Pages 660-664 (November 2017)
Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis 
Bimal Bhindi, Igor Frank, Ross J. Mason, Robert F. Tarrell, Prabin Thapa, John C. Cheville, Brian A. Costello, Lance C. Pagliaro, R. Jeffrey Karnes, R. Houston Thompson, Matthew K. Tollefson, Stephen A. Boorjian 
European Urology 
Volume 72, Issue 5, Pages (November 2017)
DOI: /j.eururo
Copyright © 2017 European Association of Urology Terms and Conditions

2. Fig. 1
Kaplan Meier analyses for recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS) for patients without (ypT0N0/pT0N0) and with residual urothelial carcinoma of the bladder (rUCB) at radical cystectomy (RC) following neoadjuvant chemotherapy (NAC) in comparison to pathologic stage–matched controls.
European Urology  , DOI: ( /j.eururo )
Copyright © 2017 European Association of Urology Terms and Conditions